FDA Inspection 1065227 — Haleon US Holdings LLC

Haleon US Holdings LLC — FEI 1314819

The FDA completed an inspection of Haleon US Holdings LLC on September 11, 2018 in East Durham, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 11, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
East Durham, NY (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
358521 CFR 211.110(a)Control procedures to monitor and validate performance